PD-L1 Expression in Lung Adenocarcinomas Correlates with KRAS Mutations and Th1/Cytotoxic T Lymphocyte Microenvironment

被引：0

作者：

Huynh, Tiffany ^{[1
]}

Morales-Oyarvide, Vicente ^{[2
]}

Uruga, Hironori ^{[1
]}

Bozkurtlar, Emine ^{[1
]}

Gainor, Justin F. ^{[3
]}

Hata, Aaron ^{[3
]}

Mark, Eugene ^{[1
]}

Lanuti, Michael ^{[4
]}

Engelman, Jeffrey A. ^{[5
]}

Mino-Kenudson, Mari ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[4] Massachusetts Gen Hosp, Thorac Surg, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

Immunotherapy; Tumor biology; lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL13.01

引用

页码：S198 / S198

页数：1

共 50 条

[21] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
Kang Li
Jun Liu
Lin Wu
Yajie Xiao
Jia Li
Haijian Du
Zhikun Zhao
Chao Sun
Yongtian Zhao
Jie Yang
Dongfang Wu
Zhuxiang Zhao
Bolin Chen
Cancer Cell International, 22
[22] Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer
Ozilhan, Seda Er
Efil, Safa Can
Canakci, Dogukan
Agackiran, Yetkin
Dede, Didem Sener
Kandemir, Nilufer Onak
Dogan, Mehmet
Unal, Tuba Dilay Kokenek
Kiran, Merve Meryem
Kayacetin, Serra
Balta, Hilal
Dogan, Hayriye Tatli
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (02)
[23] Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
Li, Kang
Liu, Jun
Wu, Lin
Xiao, Yajie
Li, Jia
Du, Haijian
Zhao, Zhikun
Sun, Chao
Zhao, Yongtian
Yang, Jie
Wu, Dongfang
Zhao, Zhuxiang
Chen, Bolin
CANCER CELL INTERNATIONAL, 2022, 22 (01)
[24] Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Koirala, Pratistha
Roth, Michael E.
Gill, Jonathan
Piperdi, Sajida
Chinai, Jordan M.
Geller, David S.
Hoang, Bang H.
Park, Amy
Fremed, Michael A.
Zang, Xingxing
Gorlick, Richard
SCIENTIFIC REPORTS, 2016, 6
[25] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
Saito, Hiroaki
Kono, Yusuke
Murakami, Yuki
Shishido, Yuji
Kuroda, Hirohiko
Matsunaga, Tomoyuki
Fukumoto, Yoji
Osaki, Tomohiro
Ashida, Keigo
Fujiwara, Yoshiyuki
ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
[26] PD-L1: expression regulation
Zhou, Yu-Jie
Li, Guoli
Wang, Jiyin
Liu, Mengyuan
Wang, Zihan
Song, Yu
Zhang, Xulong
Wang, Xi
BLOOD SCIENCE, 2023, 5 (02): : 77 - 91
[27] Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
Bevins, Nicholas J.
Okamura, Ryosuke
Montesion, Meagan
Adashek, Jacob J.
Goodman, Aaron M.
Kurzrock, Razelle
JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (04) : 90 - 97
[28] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
Zhang, Jie
Gao, Jing
Li, Yanyan
Nie, Jun
Dai, Ling
Hu, Weiheng
Chen, Xiaoling
Han, Jindi
Ma, Xiangjuan
Tian, Guangming
Wu, Di
Shen, Lin
Fang, Jian
THORACIC CANCER, 2015, 6 (04) : 534 - 538
[29] PD-1/PD-L1 Axis in Lung Cancer
Santini, Fernando C.
Hellmann, Matthew D.
CANCER JOURNAL, 2018, 24 (01) : 15 - 19
[30] PD-L1 expression in large cell neuroendocrine carcinoma of the lung
Eichhorn, F.
Harms, A.
Warth, A.
Muley, T.
Winter, H.
Eichhorn, M. E.
LUNG CANCER, 2018, 118 : 76 - 82

← 1 2 3 4 5 →